Longitude Venture Partners L.P.'s Net Worth
$463 Million
Who is Longitude Venture Partners L.P.?
Longitude Venture Partners L.P. has an estimated net worth of $463 Million. This is based on reported shares across multiple companies, which include CORCEPT THERAPEUTICS INC, COLLEGIUM PHARMACEUTICAL, INC, and Esperion Therapeutics, Inc..
SEC CIK
Longitude Venture Partners L.P.'s CIK is 0001419701
Past Insider Trading and Trends
2015 was Longitude Venture Partners L.P.'s most active year for acquiring shares with 10 total transactions. Longitude Venture Partners L.P.'s most active month to acquire stocks was the month of February. 2014 was Longitude Venture Partners L.P.'s most active year for disposing of shares, totalling 26 transactions. Longitude Venture Partners L.P.'s most active month to dispose stocks was the month of October. 2015 saw Longitude Venture Partners L.P. paying a total of $12,133,536.06 for 6,439,904 shares, this is the most they've acquired in one year. In 2017 Longitude Venture Partners L.P. cashed out on 1,000,000 shares for a total of $17,340,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
COLLEGIUM PHARMACEUTICAL, INC (COLL) Snapshot price: $33.26
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -30.10% | -1.00M |
$17.34 | -$17,340,000.00 | 2.32M |
Dec 8
| |||
Form 4
|
∞
| 3.32M |
$12.00 |
—
| 3.32M |
May 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
CORCEPT THERAPEUTICS INC (CORT) Snapshot price: $22.35
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -21.50% | -3.00M |
—
|
—
| 10.96M |
Nov 28
| |||
Form 4
| -0.26% | -36.94K |
$9.34 | -$345,165.30 | 13.96M |
Nov 22 - Nov 25
| |||
Form 4
| -3.74% | -544.10K |
$9.56 | -$5,199,426.22 | 13.99M |
Nov 17 - Nov 21
| |||
Form 4
| -1.19% | -174.85K |
$9.55 | -$1,669,605.81 | 14.54M |
Nov 15 - Nov 16
| |||
Form 4
| +6.18% | 856.64K |
$4.05 | $3,469,408.20 | 14.71M |
Mar 30
| |||
Form 4
| +9.24% | 1.17M |
$4.29 | -$10.79 | 13.86M |
Mar 20 - Mar 24
| |||
Form 4
| -0.97% | -250.00K |
$4.10 | -$1,026,569.45 | 25.45M |
May 1 - May 2
| |||
Form 4
| -1.90% | -250.00K |
$4.28 | -$1,070,575.00 | 12.93M |
Apr 1
| |||
Form 4
| -0.63% | -250.00K |
$4.00 | -$1,000,818.05 | 39.74M |
Mar 5 - Mar 7
| |||
Form 4
| +6.81% | 856.64K |
$2.96 | $2,535,666.24 | 13.43M |
Mar 29
| |||
Form 4
| +6.34% | 750K |
$3.90 | $2,925,000.00 | 12.58M |
Jan 21
| |||
Form 4
| +7.81% | 856.64K |
$1.66 | $1,422,029.04 | 11.83M |
Apr 21
| |||
Form 4
| +28.72% | 2.45M |
$1.38 | $3,377,623.14 | 10.97M |
Oct 16
| |||
Form 4
| +119.67% | 4.64M |
$0.69 | $3,189,642.76 | 8.52M |
Feb 6
| |||
Form 4
| +9.90% | 349.43K |
$1.45 | $506,666.25 | 3.88M |
Nov 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Esperion Therapeutics, Inc. (ESPR) Snapshot price: $2.645
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -25.35% | -487.13K |
$32.78 | -$15,966,168.16 | 1.43M |
Nov 17 - Nov 18
| |||
Form 4
| -0.05% | -943.00 |
$30.00 | -$28,290.00 | 1.92M |
Oct 9
| |||
Form 4
| -0.62% | -11.93K |
$30.04 | -$358,289.49 | 1.92M |
Oct 7
| |||
Form 4
|
∞
| 1.93M |
$14.00 |
—
| 1.93M |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |